The stock of Bioceres Crop Solutions Corp (BIOX) has seen a 6.33% increase in the past week, with a -5.88% drop in the past month, and a -14.07% decrease in the past quarter. The volatility ratio for the week is 5.00%, and the volatility levels for the past 30 days are at 5.43% for BIOX. The simple moving average for the past 20 days is 3.50% for BIOX’s stock, with a -30.25% simple moving average for the past 200 days.
Is It Worth Investing in Bioceres Crop Solutions Corp (NASDAQ: BIOX) Right Now?
Bioceres Crop Solutions Corp (NASDAQ: BIOX) has a price-to-earnings ratio that is above its average at 486.96x. The stock has a 36-month beta value of 0.56. Opinions on the stock are mixed, with 4 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for BIOX is 32.43M, and at present, short sellers hold a 2.00% of that float. On January 03, 2025, the average trading volume of BIOX was 192.96K shares.
BIOX) stock’s latest price update
Bioceres Crop Solutions Corp (NASDAQ: BIOX)’s stock price has gone rise by 10.53 in comparison to its previous close of 6.08, however, the company has experienced a 6.33% increase in its stock price over the last five trading days. seekingalpha.com reported 2024-11-12 that Bioceres’ 1Q25 results were challenging due to adverse weather in Argentina, affecting crop nutrition, protection, and seeds, but potential recovery is expected in 2Q25. BIOX has depreciated significantly, now trading at $6.7 per share, with a market cap of $400 million, making it a more interesting Hold. Despite some improvements, HB4 commercialization remains underwhelming, and financial risks persist, warranting caution before investing in potential developments.
Analysts’ Opinion of BIOX
Many brokerage firms have already submitted their reports for BIOX stocks, with Canaccord Genuity repeating the rating for BIOX by listing it as a “Buy.” The predicted price for BIOX in the upcoming period, according to Canaccord Genuity is $17 based on the research report published on July 19, 2024 of the previous year 2024.
ROTH MKM, on the other hand, stated in their research note that they expect to see BIOX reach a price target of $15. The rating they have provided for BIOX stocks is “Buy” according to the report published on July 02nd, 2024.
Oppenheimer gave a rating of “Outperform” to BIOX, setting the target price at $15 in the report published on April 06th of the previous year.
BIOX Trading at 1.63% from the 50-Day Moving Average
After a stumble in the market that brought BIOX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -52.17% of loss for the given period.
Volatility was left at 5.43%, however, over the last 30 days, the volatility rate increased by 5.00%, as shares sank -1.03% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -9.43% lower at present.
During the last 5 trading sessions, BIOX rose by +6.33%, which changed the moving average for the period of 200-days by -47.38% in comparison to the 20-day moving average, which settled at $6.49. In addition, Bioceres Crop Solutions Corp saw 10.53% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for BIOX
Current profitability levels for the company are sitting at:
- 0.09 for the present operating margin
- 0.4 for the gross margin
The net margin for Bioceres Crop Solutions Corp stands at 0.01. The total capital return value is set at 0.08. Equity return is now at value 0.50, with 0.18 for asset returns.
Based on Bioceres Crop Solutions Corp (BIOX), the company’s capital structure generated 0.45 points at debt to capital in total, while cash flow to debt ratio is standing at 0.08. The debt to equity ratio resting at 0.81. The interest coverage ratio of the stock is 1.66.
Currently, EBITDA for the company is 55.46 million with net debt to EBITDA at 5.83. When we switch over and look at the enterprise to sales, we see a ratio of 1.49. The receivables turnover for the company is 2.01for trailing twelve months and the total asset turnover is 0.53. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.27.
Conclusion
To sum up, Bioceres Crop Solutions Corp (BIOX) has seen a mixed performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
